Company profile: Gossamer Bio
1.1 - Company Overview
Company description
- Provider of biopharmaceutical discovery and development of novel and differentiated therapeutic products, including seralutinib for pulmonary arterial hypertension in Phase 3 clinical trials, and offering clinical trials and an expanded access program for investigational medicines.
Products and services
- Seralutinib: A Phase 3 investigational drug under development to treat pulmonary arterial hypertension, with ongoing clinical trials assessing therapeutic effects in affected patients
- Clinical Trials: Patient-involved research studies systematically evaluating the effects of medical, surgical, or behavioral interventions on health outcomes across enrolled participants
- Expanded Access Program: Investigational access program offering case-by-case availability of medicines for patients with serious diseases or conditions outside clinical trials
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Gossamer Bio
Principia Biopharma
HQ: United States
Website
- Description: Provider of pre-clinical discovery and development of differentiated oral small-molecule therapies for inflammatory and autoimmune diseases and cancer, addressing significant unmet medical needs in immunology and oncology.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Principia Biopharma company profile →
Sudo Biosciences
HQ: United States
Website
- Description: Provider of TYK2 pseudokinase domain–targeting medicines, including a brain-penetrant TYK2 inhibitor for multiple sclerosis and neurodegenerative diseases, and a topical TYK2 inhibitor for psoriasis and other immune-mediated dermatologic conditions.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Sudo Biosciences company profile →
Allergopharma
HQ: Germany
Website
- Description: Provider of allergen-specific immunotherapy for type 1 allergies such as hay fever and allergic asthma, offering Allergen Immunotherapy (AIT) to induce immunological tolerance, reduce symptoms, and prevent the progression of allergic diseases, along with diagnostics for IgE-mediated allergies to identify triggers for targeted treatment.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Allergopharma company profile →
Proteo Biotech
HQ: Germany
Website
- Description: Provider of clinical technology focused on the discovery and development of medical treatments for disease prevention.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Proteo Biotech company profile →
Granite Bio
HQ: Switzerland
Website
- Description: Provider of novel antibody-based biotechnology to treat inflammatory, autoimmune, and fibrotic disorders.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Granite Bio company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Gossamer Bio
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Gossamer Bio
2.2 - Growth funds investing in similar companies to Gossamer Bio
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Gossamer Bio
4.2 - Public trading comparable groups for Gossamer Bio
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →